The global market for GLP-1 receptor agonists is witnessing a surge in demand due to their effectiveness in managing type 2 diabetes. Several pharmaceutical companies have secured FDA approval to produce these life-changing medications. {Novo Nordisk|Eli Lillyremains a leading manufacturer of GLP-1 receptor agonists, with well-established produ